Table 1.

Synergistic effects of gefitinib combination with rmhTRAIL in different concentration (C1)

C1	G + T
	G (μmol/L)	T (ng/mL)
		5	10	25	50	125
24 h	0.01	1.08±0.001	1.04±0.001	1.03±0.002	0.98±0.001	0.91±0.001
48 h	0.01	1.19±0.001	1.17±0.001	0.82±0.001	0.79±0.003	0.86±0.001
72 h	0.01	1.15±0.005	1.00±0.018	0.86±0.001	0.69±0.003	0.59±0.003
C1	G + T
	T (ng/mL)	G (μmol/L)
		0.005	0.01	0.05	0.1	0.5
24 h	50	1.05±0.002	0.98±0.001	0.92±0.001	0.83±0.001	0.77±0.001
48 h	50	1.17±0.001	0.97±0.001	0.92±0.003	0.93±0.007	0.83±0.018
72 h	50	1.2±0.005	0.94±0.001	0.77±0.022	0.61±0.001	0.67±0.182

Notes: G indicates gefitinib; T indicates rmhTRAIL.

Abbreviation: rmhTRAIL, recombinant mutant human tumor necrosis factor-related apoptosis-inducing ligand; h, hours